http://www.marketwatch.com/story/arrowhead-to-webcast-
analyst-day-presentation-on-hepatitis-b-candidate-arc-520-2015-09-10
PASADENA, Calif., Sep 10, 2015 (BUSINESS WIRE) -- Arrowhead Research Corporation ARWR, +1.28% a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it will host an analyst day in New York on September 24, 2015, with a presentation starting at 11:00 a.m.